Procalcitonin and C-reactive protein levels as diagnostic tools in febrile patients admitted to a General Internal Medicine ward

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 22-25

  Ruiz Esteban, Raul ^a   Sarabia, Pilar Relea ^a   Delgado, Emilio García ^a   Aguado, Carlos Barros ^a   Cuervo Arango, Jose Amerigo ^a   Varela, Manuel ^a  

^a HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

C reactive protein; Fever; Infectious diseases; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BACTERIAL INFECTION; BEHCET DISEASE; DIAGNOSTIC VALUE; DRUG INDUCED DISEASE; FEVER; HUMAN; INFECTION; INFLAMMATORY DISEASE; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; VIRUS INFECTION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEVER; HOSPITALIZATION; HUMANS; INFLAMMATION; INPATIENTS; INTERNAL MEDICINE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

EID: 84855297111     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.09.024     Document Type: Article

References (37)

1. Linscheid P., Seboek D., Schaer D.J., Zulewski H., Keller U., Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004, 32(8):1715-1721.
2. Becker K.L., Nylen E.S., White J.C., Muller B., Snider R.H. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004, 89(4):1512-1525.
3. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164(3):396-402.
4. Muller B., Becker K.L., Schachinger H., Rickenbacher P.R., Huber P.R., Zimmerli W., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28(4):977-983.
5. Castelli G.P., Pognani C., Meisner M., Stuani A., Bellomi D., Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004, 8(4):R234-R242.
6. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341(8844):515-518.
7. Nobre V., Harbarth S., Graf J.D., Rohner P., Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177(5):498-505.
8. Dahaba A.A., Hagara B., Fall A., Rehak P.H., List W.F., Metzler H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006, 97(4):503-508.
9. Jensen J.U., Heslet L., Jensen T.H., Espersen K., Steffensen P., Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34(10):2596-2602.
10. Povoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005, 11(2):101-108.
11. Yentis S.M., Soni N., Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995, 21(7):602-605.
12. Matson A., Soni N., Sheldon J. C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care 1991, 19(2):182-186.
13. Povoa P., Almeida E., Moreira P., Fernandes A., Mealha R., Aragao A., et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998, 24(10):1052-1056.
14. Peres Bota D., Melot C., Lopes Ferreira F., Vincent J.L. Infection Probability Score (IPS): a method to help assess the probability of infection in critically ill patients. Crit Care Med 2003, 31(11):2579-2584.
15. Indino P., Lemarchand P., Bady P., de Torrente A., Genne L., Genne D. Prospective study on procalcitonin and other systemic infection markers in patients with leukocytosis. Int J Infect Dis 2008, 12(3):319-324.
16. Brunkhorst F.M., Eberhard O.K., Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999, 27(10):2172-2176.
17. Mokart D., Merlin M., Sannini A., Brun J.P., Delpero J.R., Houvenaeghel G., et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005, 94(6):767-773.
18. Chiesa C., Pellegrini G., Panero A., Osborn J.F., Signore F., Assumma M., et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003, 49(1):60-68.
19. Turner D., Hammerman C., Rudensky B., Schlesinger Y., Schimmel M.S. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Paediatr 2006, 95(12):1571-1576.
20. Vazzalwar R., Pina-Rodrigues E., Puppala B.L., Angst D.B., Schweig L. Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J Perinatol 2005, 25(6):397-402.
21. Clec'h C., Fosse J.P., Karoubi P., Vincent F., Chouahi I., Hamza L., et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34(1):102-107.
22. Pettila V., Hynninen M., Takkunen O., Kuusela P., Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002, 28(9):1220-1225.
23. Hatherill M., Tibby S.M., Turner C., Ratnavel N., Murdoch I.A. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000, 28(7):2591-2594.
24. Wunder C., Eichelbronner O., Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004, 53(4):158-163.
25. Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998, 24(7):680-684.
26. Christ-Crain M., Jaccard-Stolz D., Bingisser R., Gencay M.M., Huber P.R., Tamm M., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363(9409):600-607.
27. Christ-Crain M., Stolz D., Bingisser R., Muller C., Miedinger D., Huber P.R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174(1):84-93.
28. Limper M., de Kruif M.D., Duits A.J., Brandjes D.P., van Gorp E.C. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 2010, 60(6):409-416.
29. 21-CFR-866 Immunology and microbiology devices; serological reagents 2007.
30. Becker K.L., Snider R., Nylen E.S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008, 36(3):941-952.
31. Nylen E., Muller B., Becker K.L., Snider R. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 2003, 36(6):823-824. author reply 826-7.
32. Dahaba A.A., Rehak P.H., List W.F. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003, 29(4):579-583.
33. Povoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005, 25(5):804-812.
34. Povoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 2006, 10(2):R63.
35. Lobo S.M., Lobo F.R., Bota D.P., Lopes-Ferreira F., Soliman H.M., Melot C., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123(6):2043-2049.
36. Daniels J.M., Schoorl M., Snijders D., Knol D.L., Lutter R., Jansen H.M., et al. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 2010, 138(5):1108-1115.
37. Claeys R., Vinken S., Spapen H., ver Elst K., Decochez K., Huyghens L., et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30(4):757-762.